Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
cancer
3
×
life sciences
national blog main
biotech
clinical trials
deals
ipo
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
startups
venture capital
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
armo biosciences
astrazeneca
autoimmune
avalon ventures
avapritinib
biogen
blueprint medicines
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
coi pharmaceuticals
correlation ventures
covid-19
crispr
What
plans
3
×
announced
ipo
acquisitions
advance
approval
bio
biology
blueprint
cancer
ceo
chasing
collabs
company
covid
cytokine
daniel
deadly
deal
deciphera
drug
drugs
enhanced
fda
files
filing
forms
gi
gilead
gilead’s
help
initial
introduce
laying
medicine
medicines
money
month
morning
offering
Language
unset
Current search:
plans
×
cancer
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs